Earnings Feed
Start Free
Progyny, Inc.·4

May 26, 4:21 PM ET

Payson Norman 4

4 · Progyny, Inc. · Filed May 26, 2026

Research Summary

AI-generated summary of this filing

Updated

Progyny (PGNY) Director Norman Payson Receives Equity Awards

What Happened
Norman Payson, a director of Progyny, received multiple equity awards on May 21, 2026. The Form 4 reports: 5,660 restricted stock units (RSUs) (no purchase price), 3,203 derivative shares recorded at $12.49 each (total value $40,005), and 27,119 derivative shares/units (no purchase price). These were grants/awards (not open-market purchases or sales) and appear to be compensation for board service.

Key Details

  • Transaction date: 2026-05-21; Form 4 filed 2026-05-26 (covers the 5/21 grants).
  • Reported items:
    • 5,660 RSUs (F1) — each RSU converts to one share upon vesting.
    • 3,203 derivative units reported at $12.49 each, total $40,005 (F4 indicates an option issued in lieu of a $39,990 cash retainer).
    • 27,119 derivative units (F5).
  • Vesting: RSUs and the option(s) vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately before the issuer’s first annual meeting after the grant, subject to continued service (F1, F4, F5).
  • Holdings: Some reportable securities are held by trusts or entities (The Norman C. and Melinda B. Payson Revocable Trust and EVO Eagle, LLC) where Payson has or shares voting/dispositive power (F2, F3).
  • Shares owned after the transaction: not specified in the data provided.
  • Filing timeliness: Form 4 was filed five days after the grants (5/26 for 5/21); this is the date shown on the filing.

Context

  • These transactions are awards/grants (compensation), not purchases or sales. RSUs are contingent rights to receive shares at vesting; options (or option-like awards) issued in lieu of a cash retainer will vest later and do not represent immediately tradable shares.
  • Such grants are routine for director compensation and do not by themselves indicate insider buying or selling sentiment. Watch the vesting dates and any subsequent Form 4s for potential future sales if shares become vested and are disposed.

Insider Transaction Report

Form 4
Period: 2026-05-21
Progyny, Inc.PGNY
Payson Norman
Director
Transactions
  • Award

    Common Stock

    [F1]
    2026-05-21+5,660→ 12,349 total
  • Award

    Stock Option (Right to Buy)

    [F4]
    2026-05-21$12.49/sh+3,203$40,005→ 3,203 total
    Exercise: $24.69Exp: 2036-05-20→ Common Stock (3,203 underlying)
  • Award

    Stock Option (Right to Buy)

    [F5]
    2026-05-21+27,119→ 27,119 total
    Exercise: $24.69Exp: 2036-05-20→ Common Stock (27,119 underlying)
Holdings

  • Common Stock

    [F2]
    (indirect: See footnote)
    331,363

  • Common Stock

    [F3]
    (indirect: See footnote)
    122,493
Footnotes (5)
  • [F1]Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date.
  • [F2]The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust.
  • [F3]The reportable securities are directly held by EVO Eagle, LLC. The Reporting Person shares voting and dispositive power over the securities.
  • [F4]The option was issued to the Reporting Person in lieu of an annual cash retainer of $39,990 for board and committee service. The shares subject to the option will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date.
  • [F5]The shares subject to the option will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date.
Signature
/s/ Mark Livingston, Attorney-in-Fact|2026-05-26

Documents

1 file
  • 4
    wk-form4_1779826910.xmlPrimary

    FORM 4